Gene · 8726
Papers3,114
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,114
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polycomb repressive complex 2 (PRC2) pathway's role in cancer cell plasticity and drug resistance. | Funct Integr Genomics | 2025 | 40048009 | PubTator, text mining | PubMed |
| LigExtract: Large-scale Automated Identification of Ligands from Protein Structures in the Protein Data Bank. | Genomics Proteomics Bioinformatics | 2025 | 40036758 | PubTator, text mining | PubMed |
| Mettl3/Eed/Ythdc1 regulatory axis controls endometrial receptivity and function. | Commun Biol | 2025 | 39934221 | PubTator, text mining | PubMed |
| A Sequencing Overview of Malignant Peripheral Nerve Sheath Tumors: Findings and Implications for Treatment. | Cancers (Basel) | 2025 | 39857962 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| A conserved switch to less catalytically active Polycomb repressive complexes in non-dividing cells. | Cell Rep | 2025 | 39799569 | PubTator, text mining | PubMed |
| A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies. | Eur J Cancer | 2025 | 39793445 | PubTator, text mining | PubMed |
| Structural basis for the inhibition of PRC2 by active transcription histone posttranslational modifications. | Nat Struct Mol Biol | 2025 | 39774834 | PubTator, text mining | PubMed |
| Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. | Neuro Oncol | 2025 | 39500722 | PubTator, text mining | PubMed |
| An EED/PRC2-H19 Loop Regulates Cerebellar Development. | Adv Sci (Weinh) | 2025 | 39498824 | PubTator, text mining | PubMed |
| A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins. | J Med Chem | 2025 | 39495097 | PubTator, text mining | PubMed |
| Eed controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crest. | bioRxiv | 2025 | 38558995 | PubTator, text mining | PubMed |
| Decoding the therapeutic landscape of alpha-linolenic acid: a network pharmacology and bioinformatics investigation against cancer-related epigenetic modifiers. | J Biomol Struct Dyn | 2025 | 38088751 | PubTator, text mining | PubMed |
| Pharmacological Advancements of PRC2 in Cancer Therapy: A Narrative Review. | Life (Basel) | 2024 | 39768352 | PubTator, text mining | PubMed |
| Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors. | Neurooncol Adv | 2024 | 39620202 | PubTator, text mining | PubMed |
| A polycomb group protein EED epigenetically regulates responses in lipopolysaccharide tolerized macrophages. | Epigenetics Chromatin | 2024 | 39614386 | PubTator, text mining | PubMed |
| Malignant Peripheral Nerve Sheath Tumor (MPNST) With Smooth Muscle Differentiation of the Uterus-A Case Report With Emphasis on Diagnostic Pitfalls and Value of DNA Methylation Analysis. | Genes Chromosomes Cancer | 2024 | 39508369 | PubTator, text mining | PubMed |
| Hypermethylation of CDKN2A CpG island drives resistance to PRC2 inhibitors in SWI/SNF loss-of-function tumors. | Cell Death Dis | 2024 | 39500892 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| Replication-coupled inheritance of chromatin states. | Cell Insight | 2024 | 39391004 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8726/papers?page=5